CORDIS
EU research results

CORDIS

English EN

Enabling NAnomedicine TRANSlation

Objective

ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts.
To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine.
ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market.
Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies.
Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects.
Partners in ENATRANS are VDI/VDE-IT, Nanobiotix, CEA, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi, TecMinho.

Coordinator

VDI/VDE INNOVATION + TECHNIK GMBH

Address

Steinplatz 1
10623 Berlin

Germany

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 461 050

Participants (6)

Sort alphabetically

Sort by EU Contribution

Expand all

NANOBIOTIX SA

France

EU Contribution

€ 408 250

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 287 750

GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV

Germany

EU Contribution

€ 233 125

TEL AVIV UNIVERSITY

Israel

EU Contribution

€ 163 750

FONDAZIONE DON CARLO GNOCCHI ONLUS

Italy

EU Contribution

€ 131 250

ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO

Portugal

EU Contribution

€ 314 231

Project information

Grant agreement ID: 646113

  • Start date

    1 January 2015

  • End date

    31 December 2017

Funded under:

H2020-EU.2.3.2.2.

H2020-EU.2.1.2.

H2020-EU.2.3.2.1.

  • Overall budget:

    € 1 999 406,25

  • EU contribution

    € 1 999 406

Coordinated by:

VDI/VDE INNOVATION + TECHNIK GMBH

Germany

This project is featured in...